doi: 10.3389/fphar.2020.00196
Edited by:
Emanuela Ricciotti, University of Pennsylvania, United States Reviewed by:
Lihong Chen, Dalian Medical University, China Andreas Koeberle, The University of Tokyo, Japan
*Correspondence:
Meike J. Saul saul@bio.tu-darmstadt.de
Specialty section:
This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology Received: 19 November 2019 Accepted: 13 February 2020 Published: 13 March 2020 Citation:
Emmerich AC, Wellstein J, Ossipova E, Baumann I, Lengqvist J, Kultima K, Jakobsson P-J, Steinhilber D and Saul MJ (2020) Proteomics-Based Characterization of miR-574-5p Decoy to CUGBP1 Suggests Specificity for mPGES-1 Regulation in Human Lung Cancer Cells. Front. Pharmacol. 11:196.
doi: 10.3389/fphar.2020.00196
Proteomics-Based Characterization of miR-574-5p Decoy to CUGBP1 Suggests Specificity for mPGES-1 Regulation in Human Lung Cancer Cells
Anne C. Emmerich
1,2, Julia Wellstein
1,2, Elena Ossipova
3, Isabell Baumann
1,2, Johan Lengqvist
3, Kim Kultima
4, Per-Johan Jakobsson
3, Dieter Steinhilber
2and Meike J. Saul
1,2*
1